Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Ivabradine | Ivabradine may increase the QTc-prolonging activities of Sitafloxacin. |
| Didanosine | Didanosine can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Probenecid | Probenecid may decrease the excretion rate of Sitafloxacin which could result in a higher serum level. |
| Quinapril | Quinapril can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Calcium acetate | Calcium acetate can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Sevelamer | Sevelamer can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Iron Dextran | Iron Dextran can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Calcium | Calcium can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Calcium carbonate | Calcium carbonate can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Lanthanum carbonate | Lanthanum carbonate can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Ferric carboxymaltose | Ferric carboxymaltose can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Iron sucrose | Iron sucrose can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Ferric pyrophosphate | Ferric pyrophosphate can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Calcium citrate | Calcium citrate can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Calcium gluconate | Calcium gluconate can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Ferric sulfate | Ferric sulfate can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Ferric cation | Ferric cation can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Tetraferric tricitrate decahydrate | Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Lanthanum III cation | Lanthanum III cation can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Calcium polycarbophil | Calcium polycarbophil can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Ferric oxyhydroxide | Ferric oxyhydroxide can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Sucralfate | Sucralfate can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Zolmitriptan | The metabolism of Zolmitriptan can be decreased when combined with Sitafloxacin. |
| Nitrofurantoin | The therapeutic efficacy of Sitafloxacin can be decreased when used in combination with Nitrofurantoin. |
| Mycophenolate mofetil | The serum concentration of Mycophenolate mofetil can be decreased when it is combined with Sitafloxacin. |
| Mycophenolic acid | The serum concentration of Mycophenolic acid can be decreased when it is combined with Sitafloxacin. |
| Picosulfuric acid | The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Sitafloxacin. |
| Insulin human | The therapeutic efficacy of Insulin human can be increased when used in combination with Sitafloxacin. |
| Insulin lispro | The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sitafloxacin. |
| Insulin pork | The therapeutic efficacy of Insulin pork can be increased when used in combination with Sitafloxacin. |
| Troglitazone | The therapeutic efficacy of Troglitazone can be increased when used in combination with Sitafloxacin. |
| Glimepiride | The therapeutic efficacy of Glimepiride can be increased when used in combination with Sitafloxacin. |
| Sulfisoxazole | The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Sitafloxacin. |
| Acarbose | The therapeutic efficacy of Acarbose can be increased when used in combination with Sitafloxacin. |
| Metformin | The therapeutic efficacy of Metformin can be increased when used in combination with Sitafloxacin. |
| Sulfadiazine | The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Sitafloxacin. |
| Rosiglitazone | The therapeutic efficacy of Rosiglitazone can be increased when used in combination with Sitafloxacin. |
| Acetohexamide | The therapeutic efficacy of Acetohexamide can be increased when used in combination with Sitafloxacin. |
| Miglitol | The therapeutic efficacy of Miglitol can be increased when used in combination with Sitafloxacin. |
| Chlorpropamide | The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Sitafloxacin. |
| Nateglinide | The therapeutic efficacy of Nateglinide can be increased when used in combination with Sitafloxacin. |
| Pentamidine | The therapeutic efficacy of Pentamidine can be increased when used in combination with Sitafloxacin. |
| Tolazamide | The therapeutic efficacy of Tolazamide can be increased when used in combination with Sitafloxacin. |
| Repaglinide | The therapeutic efficacy of Repaglinide can be increased when used in combination with Sitafloxacin. |
| Phenformin | The therapeutic efficacy of Phenformin can be increased when used in combination with Sitafloxacin. |
| Sulfamethoxazole | The therapeutic efficacy of Sulfamethoxazole can be increased when used in combination with Sitafloxacin. |
| Glyburide | The therapeutic efficacy of Glyburide can be increased when used in combination with Sitafloxacin. |
| Glipizide | The therapeutic efficacy of Glipizide can be increased when used in combination with Sitafloxacin. |
| Gliclazide | The therapeutic efficacy of Gliclazide can be increased when used in combination with Sitafloxacin. |
| Tolbutamide | The therapeutic efficacy of Tolbutamide can be increased when used in combination with Sitafloxacin. |
| Pioglitazone | The therapeutic efficacy of Pioglitazone can be increased when used in combination with Sitafloxacin. |
| Bromocriptine | The therapeutic efficacy of Bromocriptine can be increased when used in combination with Sitafloxacin. |
| Gliquidone | The therapeutic efficacy of Gliquidone can be increased when used in combination with Sitafloxacin. |
| Mitiglinide | The therapeutic efficacy of Mitiglinide can be increased when used in combination with Sitafloxacin. |
| Sitagliptin | The therapeutic efficacy of Sitagliptin can be increased when used in combination with Sitafloxacin. |
| Sunitinib | The therapeutic efficacy of Sunitinib can be increased when used in combination with Sitafloxacin. |
| Exenatide | The therapeutic efficacy of Exenatide can be increased when used in combination with Sitafloxacin. |
| Mecasermin | The therapeutic efficacy of Mecasermin can be increased when used in combination with Sitafloxacin. |
| Pramlintide | The therapeutic efficacy of Pramlintide can be increased when used in combination with Sitafloxacin. |
| Glisoxepide | The therapeutic efficacy of Glisoxepide can be increased when used in combination with Sitafloxacin. |
| Insulin aspart | The therapeutic efficacy of Insulin aspart can be increased when used in combination with Sitafloxacin. |
| Insulin glulisine | The therapeutic efficacy of Insulin glulisine can be increased when used in combination with Sitafloxacin. |
| Glymidine | The therapeutic efficacy of Glymidine can be increased when used in combination with Sitafloxacin. |
| AICA ribonucleotide | The therapeutic efficacy of AICA ribonucleotide can be increased when used in combination with Sitafloxacin. |
| Buformin | The therapeutic efficacy of Buformin can be increased when used in combination with Sitafloxacin. |
| Vildagliptin | The therapeutic efficacy of Vildagliptin can be increased when used in combination with Sitafloxacin. |
| Voglibose | The therapeutic efficacy of Voglibose can be increased when used in combination with Sitafloxacin. |
| NN344 | The therapeutic efficacy of NN344 can be increased when used in combination with Sitafloxacin. |
| AMG-222 | The therapeutic efficacy of AMG-222 can be increased when used in combination with Sitafloxacin. |
| Bisegliptin | The therapeutic efficacy of Bisegliptin can be increased when used in combination with Sitafloxacin. |
| Alogliptin | The therapeutic efficacy of Alogliptin can be increased when used in combination with Sitafloxacin. |
| Dapagliflozin | The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Sitafloxacin. |
| Saxagliptin | The therapeutic efficacy of Saxagliptin can be increased when used in combination with Sitafloxacin. |
| Liraglutide | The therapeutic efficacy of Liraglutide can be increased when used in combination with Sitafloxacin. |
| Gosogliptin | The therapeutic efficacy of Gosogliptin can be increased when used in combination with Sitafloxacin. |
| Linagliptin | The therapeutic efficacy of Linagliptin can be increased when used in combination with Sitafloxacin. |
| Canagliflozin | The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sitafloxacin. |
| Glibornuride | The therapeutic efficacy of Glibornuride can be increased when used in combination with Sitafloxacin. |
| Benfluorex | The therapeutic efficacy of Benfluorex can be increased when used in combination with Sitafloxacin. |
| Empagliflozin | The therapeutic efficacy of Empagliflozin can be increased when used in combination with Sitafloxacin. |
| Albiglutide | The therapeutic efficacy of Albiglutide can be increased when used in combination with Sitafloxacin. |
| Dulaglutide | The therapeutic efficacy of Dulaglutide can be increased when used in combination with Sitafloxacin. |
| Lobeglitazone | The therapeutic efficacy of Lobeglitazone can be increased when used in combination with Sitafloxacin. |
| Netoglitazone | The therapeutic efficacy of Netoglitazone can be increased when used in combination with Sitafloxacin. |
| Rivoglitazone | The therapeutic efficacy of Rivoglitazone can be increased when used in combination with Sitafloxacin. |
| Ciglitazone | The therapeutic efficacy of Ciglitazone can be increased when used in combination with Sitafloxacin. |
| Lixisenatide | The therapeutic efficacy of Lixisenatide can be increased when used in combination with Sitafloxacin. |
| Insulin beef | The therapeutic efficacy of Insulin beef can be increased when used in combination with Sitafloxacin. |
| Insulin degludec | The therapeutic efficacy of Insulin degludec can be increased when used in combination with Sitafloxacin. |
| Insulin peglispro | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Sitafloxacin. |
| Insulin tregopil | The therapeutic efficacy of Insulin tregopil can be increased when used in combination with Sitafloxacin. |
| Ipragliflozin | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Sitafloxacin. |
| Dutogliptin | The therapeutic efficacy of Dutogliptin can be increased when used in combination with Sitafloxacin. |
| Allicin | The therapeutic efficacy of Allicin can be increased when used in combination with Sitafloxacin. |
| Tofogliflozin | The therapeutic efficacy of Tofogliflozin can be increased when used in combination with Sitafloxacin. |
| Ertugliflozin | The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Sitafloxacin. |
| 2,4-thiazolidinedione | The therapeutic efficacy of 2,4-thiazolidinedione can be increased when used in combination with Sitafloxacin. |
| Teneligliptin | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Sitafloxacin. |
| Omarigliptin | The therapeutic efficacy of Omarigliptin can be increased when used in combination with Sitafloxacin. |
| Carmegliptin | The therapeutic efficacy of Carmegliptin can be increased when used in combination with Sitafloxacin. |